Federal Register of Legislation - Australian Government

Primary content

PB 9 of 2015 Determinations/Health as made
This determination amends the National Health (Weighted average disclosed price – April 2015 reduction day) Determination 2014 (PB 97 of 2014) to amend the weighted average disclosed price of certain brands, the form of 2 pharmaceutical items and revokes the weighted average disclosed price of 1 brand of pharmaceutical item.
Administered by: Health
Made 25 Feb 2015
Registered 02 Mar 2015
Tabled HR 04 Mar 2015
Tabled Senate 05 Mar 2015
Date of repeal 04 Mar 2015
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

 

PB 9 of 2015

National Health (Weighted average disclosed price –April 2015 reduction day) Amendment Determination 2015 (No.1)

National Health Act 1953

I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated: 25 February 2015

 

 

 

 

 

 

 

 

 

FELICITY MCNEILL

 

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

 


1              Name of Determination

       (1)     This Determination is the National Health (Weighted average disclosed price – April 2015 reduction day) Amendment Determination 2015 (No.1).

       (2)     This Determination may also be cited as PB 9 of 2015.

2              Commencement

                This Determination commences on the day after it is registered.

 

3                   Amendments to PB 97 of 2014

Schedule 1 amends the National Health (Weighted average disclosed price – April 2015 reduction day) Determination 2014 (PB 97 of 2014).


Schedule 1       Amendments

 

[1]     Schedule 1

omit:

152

Aspirin

Tablet 100 mg

Oral

Astrix

0.96

153

Aspirin

Tablet 100 mg

Oral

Mayne Pharma Aspirin

0.96

154

Aspirin

Tablet 100 mg

Oral

Spren 100

0.96

155

Aspirin

Tablet, dispersible, 300 mg

Oral

Solprin

1.23

 

[2]     Schedule 1

omit:

582

Exemestane

Tablet 25 mg

Oral

APO-Exemestane

71.33

583

Exemestane

Tablet 25 mg

Oral

Aromasin

71.33

584

Exemestane

Tablet 25 mg

Oral

Exaccord

71.33

585

Exemestane

Tablet 25 mg

Oral

Exemestane AN

71.33

586

Exemestane

Tablet 25 mg

Oral

Exemestane GH

71.33

587

Exemestane

Tablet 25 mg

Oral

Exemestane Pfizer

71.33

588

Exemestane

Tablet 25 mg

Oral

Exemestane Sandoz

71.33

589

Exemestane

Tablet 25 mg

Oral

Exemestane-GA

71.33

substitute:

582

Exemestane

Tablet 25 mg

Oral

APO-Exemestane

84.64

583

Exemestane

Tablet 25 mg

Oral

Aromasin

84.64

584

Exemestane

Tablet 25 mg

Oral

Exaccord

84.64

585

Exemestane

Tablet 25 mg

Oral

Exemestane AN

84.64

586

Exemestane

Tablet 25 mg

Oral

Exemestane GH

84.64

587

Exemestane

Tablet 25 mg

Oral

Exemestane Pfizer

84.64

588

Exemestane

Tablet 25 mg

Oral

Exemestane Sandoz

84.64

589

Exemestane

Tablet 25 mg

Oral

Exemestane-GA

84.64

 

[3]     Schedule 1

omit:

1080

Macrogol 3350

Oral liquid 13.125 g with electrolytes, 500 mL

Oral

Movicol Liquid

6.37

substitute:

1080

Macrogol 3350

Oral liquid 13.125 g in 25 mL with electrolytes, 500 mL

Oral

Movicol Liquid

6.37

 

[4]     Schedule 1

omit:

1259

Nevirapine

Tablet 200 mg

Oral

Nevipin

166.60

1260

Nevirapine

Tablet 200 mg

Oral

Nevirapine Alphapharm

166.60

1261

Nevirapine

Tablet 200 mg

Oral

Nevirapine RBX

166.60

1262

Nevirapine

Tablet 200 mg

Oral

Viramune

166.60

1263

Nevirapine

Tablet 400 mg (extended release)

Oral

Viramune XR

166.60

substitute:

1259

Nevirapine

Tablet 200 mg

Oral

Nevipin

198.09

1260

Nevirapine

Tablet 200 mg

Oral

Nevirapine Alphapharm

198.09

1261

Nevirapine

Tablet 200 mg

Oral

Nevirapine RBX

198.09

1262

Nevirapine

Tablet 200 mg

Oral

Viramune

198.09

1263

Nevirapine

Tablet 400 mg (extended release)

Oral

Viramune XR

198.09

 

[5]     Schedule 1

after:

2075

Tramadol

Tablet (sustained release) containing tramadol hydrochloride 200 mg

Oral

Zydol SR 200

4.14

 omit:

2076

Tramadol

Tablet (sustained release) containing tramadol hydrochloride 50 mg

Oral

Tramal SR 50

1.76

 

[6]     Schedule 2

after:

99

Ampicillin

Powder for injection 500 mg (as sodium)

Injection

Ibimicyn

3.09

insert:

99A

Aspirin

Tablet 100 mg

Oral

Astrix

1.07

99B

Aspirin

Tablet 100 mg

Oral

Mayne Pharma Aspirin

1.07

99C

Aspirin

Tablet 100 mg

Oral

Spren 100

1.07

99D

Aspirin

Tablet, dispersible, 300 mg

Oral

Solprin

1.37

 

[7]     Schedule 2

omit:

1416

Sodium chloride

I.V. infusion 154 mmol per L. 1 L

Injection

Baxter Healthcare Pty Ltd

1.27

substitute:

1416

Sodium chloride

I.V. infusion 154 mmol per L, 1 L

Injection

Baxter Healthcare Pty Ltd

1.27